Archives of Pharmacal Research

, Volume 40, Issue 11, pp 1314–1327 | Cite as

Oligonol promotes glucose uptake by modulating the insulin signaling pathway in insulin-resistant HepG2 cells via inhibiting protein tyrosine phosphatase 1B

  • Himanshu Kumar Bhakta
  • Pradeep Paudel
  • Hajime Fujii
  • Atsuya Sato
  • Chan Hum Park
  • Takako Yokozawa
  • Hyun Ah Jung
  • Jae Sue Choi
Research Article


Insulin resistance and protein tyrosine phosphatase 1B (PTP1B) overexpression are strongly associated with type 2 diabetes mellitus (T2DM), which is characterized by defects in insulin signaling and glucose intolerance. In a previous study, we demonstrated oligonol inhibits PTP1B and α-glucosidase related to T2DM. In this study, we examined the molecular mechanisms underlying the anti-diabetic effects of oligonol in insulin-resistant HepG2 cells. Glucose uptake was assessed using a fluorescent glucose tracer, 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose, and the signaling pathway was investigated by western blotting. Oligonol significantly increased insulin-provoked glucose uptake and decreased PTP1B expression, followed by modulation of ERK phosphorylation. In addition, oligonol activated insulin receptor substrate 1 by reducing phosphorylation at serine 307 and increasing that at tyrosine 895, and enhanced the phosphorylations of Akt and phosphatidylinositol 3-kinase. Interestingly, it also reduced the expression of two key enzymes of gluconeogenesis (glucose 6-phosphatase and phosphoenolpyruvate carboxykinase), attenuated oxidative stress by scavenging/inhibiting peroxynitrite, and reactive oxygen species (ROS) generation, and augmented the expression of nuclear factor kappa B. These findings suggest oligonol improved the insulin sensitivity of insulin-resistant HepG2 cells by attenuating the insulin signaling blockade and modulating glucose uptake and production. Furthermore, oligonol attenuated ROS-related inflammation and prevented oxidative damage in our in vitro model of type 2 diabetes. These result indicate oligonol has promising potential as a treatment for T2DM.


Protein tyrosine phosphatase 1B Diabetes mellitus Insulin-resistant HepG2 cells Oligonol Glucose uptake Insulin signaling 


Compliance with ethical standards

Conflict of interest

J. S. Choi is a Consultant for Amino Up Chemical Co. Ltd., which partly funded this research, and provided the test material, Oligonol. H. Fujii and A. Sato are in an employment relationship with the Amino Up Chemical Co. Ltd. H. A. Jung, T. Yokozawa, C. H. Park, H. K. Bhakta and P. Paudel state that there are no conflicts of interest.


  1. Brat P, George S, Bellamy A, Du Chaffaut L, Scalbert A, Mennen L, Arnault N, Amiot MJ (2006) Daily polyphenol intake in France from fruit and vegetables. J Nutr 136:2368–2373PubMedGoogle Scholar
  2. Byon JC, Kusari AB, Kusari J (1998) Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. Mol Cell Biochem 182:101–108CrossRefPubMedGoogle Scholar
  3. Cheung A, Kusari J, Jansen D, Bandyopadhyay D, Kusari A, Bryer-Ash M (1999) Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus. J Lab Clin Med 134:115–123CrossRefPubMedGoogle Scholar
  4. Choi JS, Bhakta HK, Fujii H, Min BS, Park CH, Yokozawa T, Jung HA (2016) Inhibitory evaluation of oligonol on α-glucosidase, protein tyrosine phosphatase 1B, cholinesterase, and β-secretase 1 related to diabetes and Alzheimer’s disease. Arch Pharmacal Res 39:409–420CrossRefGoogle Scholar
  5. Cordero-Herrera I, Martin MA, Goya L, Ramos S (2014) Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells. Food Chem Toxicol 64:10–19CrossRefPubMedGoogle Scholar
  6. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785–789CrossRefPubMedGoogle Scholar
  7. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C (2003) PI3K/Akt and apoptosis: size matters. Oncogene 22:8983–8998CrossRefPubMedGoogle Scholar
  8. Fujii H, Sun B, Nishioka H, Hirose A, Aruoma OI (2007) Evaluation of the safety and toxicity of the oligomerized polyphenol Oligonol. Food Chem Toxicol 45:378–387CrossRefPubMedGoogle Scholar
  9. Hung HY, Qian K, Morris-Natschke SL, Hsu CS, Lee KH (2012) Recent discovery of plant-derived anti-diabetic natural products. Nat Prod Rep 29:580–606CrossRefPubMedGoogle Scholar
  10. Kandasamy N, Ashokkumar N (2014) Protective effect of bioflavonoid myricetin enhances carbohydrate metabolic enzymes and insulin signaling molecules in streptozotocin-cadmium induced diabetic nephrotoxic rats. Toxicol Appl Pharmacol 279:173–185CrossRefPubMedGoogle Scholar
  11. King GL (2008) The role of inflammatory cytokines in diabetes and its complications. J Periodontol 79:1527–1534CrossRefPubMedGoogle Scholar
  12. Kitadate K, Homma K, Roberts A, Maeda T (2014) Thirteen-week oral dose toxicity study of oligonol containing oligomerized polyphenols extracted from lychee and green tea. Regul Toxicol Pharmacol 68:140–146CrossRefPubMedGoogle Scholar
  13. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH (2000) Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479–5489CrossRefPubMedPubMedCentralGoogle Scholar
  14. Konner AC, Brüning JC (2011) Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol Metab 22:16–23CrossRefPubMedGoogle Scholar
  15. Kooy NW, Royall JA, Ischiropoulos H, Beckman JS (1994) Peroxynitrite mediated oxidation of dihydrorhodamine 123. Free Radic Biol Med 16:149–156CrossRefPubMedGoogle Scholar
  16. Koren S, Fantus IG (2007) Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus. Best Pract Res Clin Endocrinol Metab 21:621–640CrossRefPubMedGoogle Scholar
  17. Kundu JK, Chang EJ, Fujii H, Sun B, Surh YJ (2008) Oligonol inhibits UVB-induced COX-2 expression in HR-1 hairless mouse skin AP-1 and C/EBP as potential upstream targets. Photochem Photobiol 84:399–406CrossRefPubMedGoogle Scholar
  18. Lebel CP, Bondy SC (1990) Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes. Neurochem Int 17:435–440CrossRefPubMedGoogle Scholar
  19. Liu ZQ, Liu T, Chen C, Li MY, Wang ZY, Chen RS, Wei GX, Wang XY, Luo DQ (2015) Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice. Toxicol Appl Pharmacol 285:61–70CrossRefPubMedGoogle Scholar
  20. Maeda A, Kai K, Ishii M, Ishii T, Akagawa M (2014) Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice. Mol Nutr Food Res 58:1177–1189CrossRefPubMedGoogle Scholar
  21. Miura T, Kitadate K, Fujii H (2010) The function of the next generation polyphenol, “Oligonol”. In: Bagchi D, Lau FC, Ghosh DK (eds) Biotechnology in functional foods and nutraceuticals. CRC Press, Boca Raton, p 91CrossRefGoogle Scholar
  22. Mossman T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 65:55–63CrossRefGoogle Scholar
  23. Mukherjee B, Hossain CM, Mondal L, Paul P, Ghosh MK (2013) Obesity and insulin resistance: an abridged molecular correlation. Lipid Insights 6:1–11CrossRefPubMedPubMedCentralGoogle Scholar
  24. Newgard CB, Brady MJ, O’Doherty RM, Saltiel AR (2000) Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1. Diabetes 49:1967–1977CrossRefPubMedGoogle Scholar
  25. Nishioka H, Fujii H, Sun B, Aruoma OI (2006) Comparative efficacy of oligonol, catechin and (−)-epigallocatechin 3-O-gallate in modulating the potassium bromate-induced renal toxicity in rats. Toxicology 226:181–187CrossRefPubMedGoogle Scholar
  26. Nonaka GI, Sun B, Yuan L, Nakagawa T, Fujii H, Surh YJ. Sulfur containing proanthocyanidin oligomer composition and process for producing the same. International Patent Application No. WO/2004/103988 A1Google Scholar
  27. Panzhinskiy E, Ren J, Nair S (2013) Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus. Curr Med Chem 20:2609–2625CrossRefPubMedGoogle Scholar
  28. Patel S, Santani D (2009) Role of NF-kB in the pathogenesis of diabetes and its associated complication. Pharmacol Rep 61:595–603CrossRefPubMedGoogle Scholar
  29. Pawson T (1995) Protein modules and signalling networks. Nature 373:573–580CrossRefPubMedGoogle Scholar
  30. Popov D (2011) Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control. Biochem Biophys Res Commun 410:377–381CrossRefPubMedGoogle Scholar
  31. Ragheb R, Shanab GM, Medhat AM, Seoudi DM, Adeli K, Fantus IG (2009) Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: evidence for PKC activation and oxidative stress-activated signaling pathways. Biochem Biophys Res Commun 389:211–216CrossRefPubMedPubMedCentralGoogle Scholar
  32. Rochester CD, Akiyode O (2014) Novel and emerging diabetes mellitus drug therapies for the type 2 diabetes patient. World J Diabetes 5:305–315CrossRefPubMedPubMedCentralGoogle Scholar
  33. Ross JA, Kasum CM (2002) Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22:19–34CrossRefPubMedGoogle Scholar
  34. Sakurai T, Nishioka H, Fujii H, Nakano N, Kizaki T, Radak Z, Izawa T, Haga S, Ohno H (2008) Antioxidative effects of a new lychee fruit-derived polyphenol mixture, oligonol, converted into a low-molecular form in adipocytes. Biosci Biotechnol Biochem 72:463–476CrossRefPubMedGoogle Scholar
  35. Shen SC, Cheng FC, Wu NJ (2008) Effect of guava (Psidium guajava Linn.) leaf soluble solids on glucose metabolism in type 2 diabetic rats. Phytother Res 22:1458–1464CrossRefPubMedGoogle Scholar
  36. Tahrani AA, Bailey CJ, Del Prato S, Barnett AH (2011) Management of type 2 diabetes: new and future developments in treatment. Lancet 378:82–197CrossRefGoogle Scholar
  37. Takada M, Sumi M, Maeda A, Watanabe F, Kamiya T, Ishii T, Nakano M, Akagawa M (2012) Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-A(y) mice. Biochem Biophys Res Commun 428:315–320CrossRefPubMedGoogle Scholar
  38. Tanaka T, Yoshitake N, Zhao P, Matsuo Y, Kouno I, Nonaka GI (2007) Production of oligomeric proanthocyanidins by fragmentation of polymers. Jpn J Food Chem 14:134Google Scholar
  39. Tiganis T (2013) PTP1B and TCPTP-nonredundant phosphatases in insulin signaling and glucose homeostasis. FEBS J 280:445–458CrossRefPubMedGoogle Scholar
  40. Tomobe K, Fujii H, Sun B, Nishioka H, Aruoma OI (2007) Modulation of infection induced inflammation and locomotive deficit and longevity in senescence accelerated mice prone (SAMP8) model by the oligomerized polyphenol oligonol. Biomed Pharmacother 61:427–434CrossRefPubMedGoogle Scholar
  41. Tsai J, Zhang R, Qiu W, Su Q, Naples M, Adeli K (2009) Inflammatory NF kappa B activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production. Am J Physiol Gastrointest Liver Physiol 296:1287–1298CrossRefGoogle Scholar
  42. Vitaglione P, Morisco F, Caporaso N, Fogliano V (2004) Dietary antioxidant compounds and liver health. Crit Rev Food Sci Nutr 44:575–586CrossRefPubMedGoogle Scholar
  43. Weiss R, Bremer AA, Lustig RH (2013) What is metabolic syndrome, and why are children getting it? Ann NY Acad Sci 1281:123–140CrossRefPubMedPubMedCentralGoogle Scholar
  44. White MF (1998) The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 182:3–11CrossRefPubMedGoogle Scholar
  45. White MF (2002) IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 283:413–422CrossRefGoogle Scholar
  46. Xie W, Wang W, Su H, Xing D, Pan Y, Du L (2006) Effect of ethanolic extracts of Ananas comosus L. leaves on insulin sensitivity in rats and HepG2. Comp Biochem Physiol C 143:429–435CrossRefGoogle Scholar
  47. Zabolotny JM, Haj FG, Kim YB, Kim HJ, Shulman GI, Kim JK, Neel BG, Kahn BB (2004) Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J Biol Chem 279:24844–24851CrossRefPubMedGoogle Scholar
  48. Zhang S, Zhang ZY (2007) PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. Drug Discov Today 12:373–381CrossRefPubMedGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 2017

Authors and Affiliations

  • Himanshu Kumar Bhakta
    • 1
  • Pradeep Paudel
    • 1
  • Hajime Fujii
    • 2
  • Atsuya Sato
    • 2
  • Chan Hum Park
    • 3
  • Takako Yokozawa
    • 4
  • Hyun Ah Jung
    • 5
  • Jae Sue Choi
    • 1
  1. 1.Department of Food and Life SciencePukyong National UniversityBusanRepublic of Korea
  2. 2.Amino Up Chemical Company Ltd.SapporoJapan
  3. 3.Department of Medicinal Crop Research, National Institute of Horticultural and Herbal ScienceRural Development AdministrationEumseongRepublic of Korea
  4. 4.Graduate School of Science and Engineering for ResearchUniversity of ToyamaToyamaJapan
  5. 5.Department of Food Science and Human NutritionChonbuk National UniversityJeonjuRepublic of Korea

Personalised recommendations